Multiple preclinical studies have consistently demonstrated a close relationship between the pathogenesis of IPF and inflammatory responses mediated by the transforming growth factor-β (TGF-β) signaling pathway. This evidence concerns the gene TGFB1 and idiopathic interstitial pneumonia.